Medicare AdvantagePrior AuthMedium impact
Qulipta (atogepant) (Revised)
Humana·Neurology, Family Medicine, Internal Medicine +1 more·Medicare Advantage
Effective date
Jan 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage now requires prior authorization for Qulipta (atogepant) tablets used for migraine prevention, effective January 1, 2025. The approval criterion is simple - the medication must be used for preventative treatment of migraines, with initial and renewal approvals lasting one plan year each.
Action Required
Immediately: Billing team must update prior authorization workflows for Qulipta (atogepant) prescriptions for Humana Medicare Advantage patients. Providers must obtain prior auth by confirming the medication will be used for migraine prevention. Submit requests through www.humana.com/PAL for medical billing codes. Claims without prior authorization will be denied.